Pilot study explored the application of MDMA-assisted psychotherapy in 18 individuals experiencing moderate to severe anxiety following diagnosis with a life-threatening illness. The primary outcome, change …
Following the passage of all nine statewide ballot measures to reform drug policies across the United States, including the first measure to decriminalize drug possession in Oregon with a Portugal-inspired …
Santa Cruz, CA, September 23, 2020 — Rick Doblin, Ph.D., Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS), and Amy Emerson, Chief Executive Officer of MAPS Public …
PRESS RELEASE: Psychedelic Research Fundraising Campaign Attracts $30 Million in Donations in 6 Months, Prepares MDMA-Assisted Therapy for FDA Approval Tim Ferriss, Mental Health Contributors Bring Psychedelic …
MAPS Public Benefit Corporation (MAPS PBC) welcomes Jason Pyle, an experienced CEO and executive leader, to their Board of Directors. A wholly-owned subsidiary of the Multidisciplinary Association of Psychedelic …
Today, the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) announced the publication of the long-term follow-up results of six Phase 2 clinical trials of MDMA-assisted psychotherapy …
The killings of George Floyd, Breonna Taylor, Ahmaud Arbery, Tony McDade, and others, along with the story of Amy Cooper’s attempt to frame Christian Cooper, have shined a light on systemic racism. These …
An independent Data Monitoring Committee has reviewed data from MAPS’ ongoing Phase 3 clinical trial The results are the strongest confirmation that an interim analysis can provide MAPS and the Psychedelic …
As a non-profit organization focused onstrengtheningmental health services, MAPS iscommitted to protecting the safety of our study staff and clinical trial participants. We are taking active measures to …
PRESS RELEASE: Israel Embraces Research on MDMA-Assisted Therapy for PTSD First two Israeli participants complete treatment in Phase 3 clinical trial of MDMA-assisted psychotherapy for PTSD Israel is first …
PRESS RELEASE: FDA Agrees to Expanded Access Program for MDMA-Assisted Therapy for PTSD Patients to receive early access to treatment outside of Phase 3 trials Program will enroll 50 PTSD patients at up …
